146 related articles for article (PubMed ID: 12946227)
1. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.
Salama ME; Worsham MJ; DePeralta-Venturina M
Arch Pathol Lab Med; 2003 Sep; 127(9):1176-81. PubMed ID: 12946227
[TBL] [Abstract][Full Text] [Related]
2. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
4. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
Velickovic M; Delahunt B; Störkel S; Grebem SK
Cancer Res; 2001 Jun; 61(12):4815-9. PubMed ID: 11406557
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study.
Mai KT; Faraji H; Desantis D; Robertson SJ; Belanger EC; Levac J
Virchows Arch; 2010 Jan; 456(1):77-84. PubMed ID: 20033232
[TBL] [Abstract][Full Text] [Related]
6. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
7. Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy.
Corless CL; Aburatani H; Fletcher JA; Housman DE; Amin MB; Weinberg DS
Diagn Mol Pathol; 1996 Mar; 5(1):53-64. PubMed ID: 8919546
[TBL] [Abstract][Full Text] [Related]
8. Intragenic PTEN/MMAC1 loss of heterozygosity in conventional (clear-cell) renal cell carcinoma is associated with poor patient prognosis.
Velickovic M; Delahunt B; McIver B; Grebe SK
Mod Pathol; 2002 May; 15(5):479-85. PubMed ID: 12011252
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
12. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
[TBL] [Abstract][Full Text] [Related]
13. Interphase cytogenetics of multicentric renal cell tumours confirm associations of specific aberrations with defined cytomorphologies.
Amo-Takyi BK; Mittermayer C; Günther K; Handt S
Br J Cancer; 2000 Apr; 82(8):1407-14. PubMed ID: 10780519
[TBL] [Abstract][Full Text] [Related]
14. End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.
Hes O; Síma R; Nemcová J; Hora M; Bulimbasic S; Kazakov DV; Urge T; Reischig T; Dvorák M; Michal M
Virchows Arch; 2008 Oct; 453(4):313-9. PubMed ID: 18795325
[TBL] [Abstract][Full Text] [Related]
15. Losses at 3p common deletion sites in subtypes of kidney tumours: histopathological correlations.
Hadaczek P; Podolski J; Toloczko A; Kurzawski G; Sikorski A; Rabbitts P; Huebner K; Lubinski J
Virchows Arch; 1996 Sep; 429(1):37-42. PubMed ID: 8865851
[TBL] [Abstract][Full Text] [Related]
16. Multifocal renal cancer: genetic basis and its medical relevance.
Bottaro DP; Linehan WM
Clin Cancer Res; 2005 Oct; 11(20):7206-8. PubMed ID: 16243789
[No Abstract] [Full Text] [Related]
17. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.
Kattar MM; Grignon DJ; Wallis T; Haas GP; Sakr WA; Pontes JE; Visscher DW
Mod Pathol; 1997 Nov; 10(11):1143-50. PubMed ID: 9388066
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
19. Detailed microsatellite analysis of chromosome 3p region in non-papillary renal cell carcinomas.
Chudek J; Wilhelm M; Bugert P; Herbers J; Kovacs G
Int J Cancer; 1997 Oct; 73(2):225-9. PubMed ID: 9335447
[TBL] [Abstract][Full Text] [Related]
20. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma.
Cossu-Rocca P; Eble JN; Delahunt B; Zhang S; Martignoni G; Brunelli M; Cheng L
Mod Pathol; 2006 Apr; 19(4):488-93. PubMed ID: 16554730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]